Neoplasia Practice Questions

Q: Carcinoembryonic antigen (CEA) is increased in all of the following conditions except:

Osteogenic sarcoma. **Explanation:** Carcinoembryonic antigen (CEA) is a high-molecular-weight glycoprotein that belongs to the immunoglobulin superfamily. It is primarily an **oncofetal antigen**, normally produced during fetal development by the gastrointestinal tract, liver, and pancreas, but its levels become negligible after birth. **1. Why Osteogenic Sarcoma is the Correct Answer:** CEA is a marker for **epithelial tumors** (carcinomas). **Osteogenic sarcoma** is a primary malignant tumor of the bone derived from mesenchymal stem cells (a sarcoma). Since it is not of epithelial origin, it does not produce CEA. The characteristic marker for Osteogenic sarcoma is **Alkaline Phosphatase (ALP)**, which correlates with osteoblastic activity and tumor burden. **2. Analysis of Incorrect Options:** * **Colon Cancer:** CEA is the classic tumor marker for colorectal carcinoma. While not used for screening (due to low sensitivity in early stages), it is the gold standard for **monitoring recurrence** and response to treatment. * **Lung Cancer:** CEA levels are frequently elevated in non-small cell lung cancer (NSCLC), particularly **adenocarcinoma**. * **Breast Cancer:** CEA, along with CA 15-3, is often elevated in advanced or metastatic breast cancer and is used to monitor therapeutic efficacy. **High-Yield Clinical Pearls for NEET-PG:** * **Non-Neoplastic elevations of CEA:** Heavy smoking (most common non-cancer cause), cirrhosis, pancreatitis, ulcerative colitis, and COPD. * **Main Clinical Use:** CEA is **not** for diagnosis/screening; it is for **prognosis and longitudinal follow-up** to detect recurrence. * **Rule of Thumb:** If a question asks about CEA, look for an "Epithelial vs. Mesenchymal" distinction. Sarcomas and Lymphomas generally do not raise CEA.

Q: Which of the following markers indicates an increased risk of recurrent carcinoma breast?

CA 27-29. **Explanation:** The correct answer is **C. CA 27-29**. **Clinical Concept:** Tumor markers are biochemical substances used to monitor treatment response and detect recurrence in malignancy. For breast cancer, the most specific markers are **CA 15-3** and **CA 27-29**. Both are directed against different epitopes of the same antigen, the **MUC1 gene product** (mucin). CA 27-29 is considered slightly more sensitive than CA 15-3. An elevation in these markers in a patient previously treated for breast cancer is highly suggestive of disease recurrence or systemic metastasis, often predating clinical or radiological findings. **Analysis of Incorrect Options:** * **A. CA 125:** This is the primary marker for **Epithelial Ovarian Cancer**. While it can be elevated in various physiological (menstruation) and pathological (endometriosis, pelvic inflammatory disease) conditions, it is not specific to breast cancer. * **B. CA 19-9:** This is the marker of choice for **Pancreatic Adenocarcinoma** and is also used in biliary tract cancers (cholangiocarcinoma). * **D. PSA (Prostate-Specific Antigen):** This is a highly specific marker for **Prostate Cancer** and is used for screening, monitoring, and detecting recurrence in males. **High-Yield Pearls for NEET-PG:** * **Most sensitive marker for Breast Cancer recurrence:** CA 27-29. * **Standard marker for Breast Cancer monitoring:** CA 15-3. * **Carcinoembryonic Antigen (CEA):** Also used in breast cancer monitoring but is less specific than CA 15-3/CA 27-29 (primarily associated with Colorectal Cancer). * **Triple Negative Breast Cancer (TNBC):** Generally lacks reliable serum tumor markers, making clinical and radiological follow-up crucial. * **HER2/neu:** While a prognostic marker/target for therapy (Trastuzumab), it is not typically used as a circulating serum marker for recurrence in the same way as CA 27-29.

Q: What is the typical nuclear cytoplasmic ratio in malignant cells?

1:1. **Explanation:** In pathology, the **Nuclear-Cytoplasm (N:C) ratio** is a critical morphological hallmark used to differentiate benign from malignant cells. [1] **1. Why 1:1 is Correct:** In normal, mature cells, the nucleus is relatively small compared to the volume of the cytoplasm, typically maintaining a ratio of **1:4 or 1:6**. However, malignant cells undergo rapid proliferation and metabolic hyperactivity. This leads to **nuclear enlargement (macronucleosis)** due to increased DNA content (polyploidy/aneuploidy), chromatin redistribution, and enlarged nucleoli. [1] As the nucleus expands to occupy a significant portion of the cell volume, the ratio shifts toward **1:1**. **2. Analysis of Incorrect Options:** * **Options A (1:6) and B (1:5):** These represent the **normal physiological range** for most resting or differentiated human cells. A high volume of cytoplasm relative to the nucleus indicates cellular maturity and specialized function rather than malignancy. * **Option D (6:4):** While malignant nuclei are large, a ratio where the nucleus significantly exceeds the total cell volume (beyond 1:1) is not the standard textbook definition for the **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 276-280.

Q: Pyrimidine dimers are a characteristic feature in which condition?

Xeroderma pigmentosum. Explanation: 1. Why Xeroderma Pigmentosum (XP) is correct: Pyrimidine dimers (specifically thymine dimers) are the hallmark DNA lesion caused by Ultraviolet (UV) radiation [1]. In healthy individuals, these dimers are repaired via the Nucleotide Excision Repair (NER) pathway. Xeroderma pigmentosum is an autosomal recessive disorder characterized by a genetic deficiency in the enzymes required for NER (most commonly UV-specific endonucleases) [1]. Consequently, pyrimidine dimers accumulate, leading to mutations in proto-oncogenes and tumor suppressor genes, which manifests as extreme photosensitivity and a 2000-fold increased risk of skin cancers (BCC, SCC, and Melanoma) [1]. 2. Why other options are incorrect: * Alkylating agents (Option B): These are chemical mutagens that typically cause the cross-linking of DNA strands or the addition of methyl/ethyl groups to bases (e.g., O6-methylguanine), rather than pyrimidine dimers. * X-rays and Gamma rays (Options C & D): These represent ionizing radiation [1]. Unlike UV light, ionizing radiation causes cell injury by generating free radicals (indirect action) or by causing single and double-strand DNA breaks and particulate damage [1]. They do not specifically produce pyrimidine dimers. High-Yield Clinical Pearls for NEET-PG: * NER Pathway: Remember the mnemonic "NER is for UV"—Nucleotide Excision Repair fixes UV damage [1]. * Clinical Triad of XP: Severe sunburn on minimal exposure, "parchment-like" skin (xeroderma), and hyperpigmented macules (freckling). * Associated Cancers: XP patients often develop skin malignancies before the age of 10 [1]. * Other Repair Defects: Contrast XP with Lynch Syndrome (Mismatch Repair defect) and Ataxia-Telangiectasia (defect in repair of double-strand breaks caused by ionizing radiation) [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 322-323.

Q: What is thrombospondin?

An angiogenesis inhibiting protein. ### Explanation **Thrombospondin-1 (TSP-1)** is a multi-domain glycoprotein found in the extracellular matrix and stored within the alpha-granules of platelets. In the context of histology and tumor biology, it is primarily recognized as a potent **endogenous inhibitor of angiogenesis**. **1. Why Option D is Correct:** Thrombospondin-1 inhibits angiogenesis through a dual mechanism: * **Direct Effect:** It binds to the **CD36 receptor** on endothelial cells, triggering apoptosis (programmed cell death). * **Indirect Effect:** It binds to and sequesters Vascular Endothelial Growth Factor (**VEGF**), preventing it from interacting with its receptors, thereby halting the formation of new blood vessels. This makes it a key player in the "angiogenic switch" during tumor progression. **2. Why Other Options are Incorrect:** * **Option A & B:** While the name "thrombospondin" suggests a role in thrombosis, it is not a primary coagulation factor (like Fibrinogen or Prothrombin). While it is released during platelet activation and aids in platelet aggregation, its defining physiological role in competitive exams is its anti-angiogenic property. * **Option C:** Contractile proteins refer to Actin and Myosin found in muscle fibers. Thrombospondin is an adhesive glycoprotein of the extracellular matrix, not a contractile element. **3. High-Yield Clinical Pearls for NEET-PG:** * **Tumor Suppressor Link:** The expression of Thrombospondin-1 is positively regulated by the **p53 tumor suppressor gene**. Loss of p53 leads to decreased TSP-1 levels, favoring tumor angiogenesis. * **Alpha-Granules:** Remember that TSP-1 is stored in **alpha-granules** of platelets (along with PDGF, TGF-β, and PF4), not dense granules. * **Wound Healing:** Beyond angiogenesis, it plays a role in cell-to-cell and cell-to-matrix interactions during tissue repair. ### Available References (numbered 1 to 5)

Question 1

What is the nature of a hamartoma?

Accepted Answer

Non-neoplastic

Answer

Neoplastic

Answer

Afflicted by trauma

Answer

Hormonal disturbance

Question 2

Which of the following tumors is the prototype of hereditary tumors of childhood?

Accepted Answer

Retinoblastoma

Answer

Leukemia

Answer

Neuroblastoma

Answer

Wilms tumor

Question 3

Carcinoembryonic antigen (CEA) is increased in all of the following conditions except:

Accepted Answer

Osteogenic sarcoma

Answer

Lung cancer

Answer

Breast cancer

Answer

Colon cancer

Question 4

Which of the following markers indicates an increased risk of recurrent carcinoma breast?

Accepted Answer

CA 27-29

Answer

CA 125

Answer

CA 19-9

Answer

PSA

Question 5

What is the typical nuclear cytoplasmic ratio in malignant cells?

Accepted Answer

1:1

Answer

1:6

Answer

1:5

Answer

6:4

Question 6

Loss of heterozygosity means?

Accepted Answer

Loss of a normal allele in a heterozygous gene.

Answer

Loss of a single arm of a chromosome.

Answer

Loss of a mutant allele in a mutant gene.

Answer

Loss of a normal allele in a normal gene.

Question 7

Which feature is the most reliable indicator of a malignant tumor?

Accepted Answer

Metastasis

Answer

Local invasion

Answer

Rapid growth

Answer

Poor differentiation

Question 8

Pyrimidine dimers are a characteristic feature in which condition?

Accepted Answer

Xeroderma pigmentosum

Answer

Alkylating agents

Answer

X-rays

Answer

Gamma rays

Question 9

What is thrombospondin?

Accepted Answer

An angiogenesis inhibiting protein

Answer

A coagulation protein

Answer

A coagulation promoting protein

Answer

A contractile protein

Question 10

Which of the following is NOT a tissue or tumor-specific tumor marker?

Accepted Answer

LDH

Answer

PSA

Answer

Calcitonin

Answer

Catecholamines

Neoplasia — MCQs

Neoplasia — MCQs

On this page

Practice by Chapter

Want unlimited practice?